ImageneBio (IMA) Cash from Operations (2020 - 2025)

ImageneBio has disclosed Cash from Operations across 6 years of filings, most recently posting 26642000.0 for Q3 2025.

• Cash from Operations for Q3 2025 came in at 26642000.0, down 305.54% year-over-year; the trailing twelve-month figure through Sep 2025 was 68786000.0 (down 73.43% YoY), and the FY2024 annual result was 46004000.0, up 42.31% from the prior year.
• Cash from Operations came in at 26642000.0 for Q3 2025 at ImageneBio, down from 6754000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 12962000.0 in Q3 2024 to a low of 28160000.0 in Q4 2024.
• The 5-year median for Cash from Operations is 17990000.0 (2021), against an average of 15828105.26.
• Across the five-year window, Cash from Operations soared 164.82% in 2024 and plunged 305.54% in 2025, its largest moves.
• ImageneBio's Cash from Operations stood at 13368000.0 in 2021, then tumbled by 32.07% to 17655000.0 in 2022, then fell by 23.59% to 21819000.0 in 2023, then fell by 29.06% to 28160000.0 in 2024, then climbed by 5.39% to 26642000.0 in 2025.
• The last three Cash from Operations figures came in at 26642000.0 (Q3 2025), 6754000.0 (Q2 2025), and 7230000.0 (Q1 2025), per Business Quant data.